A

LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype

Clinical and Translational Medicine, vol. 14, pp. e70134

Abstract

Abstract Background The complex aetiology of type 1 diabetes (T1D), characterised by a detrimental cross‐talk between the immune system and insulin‐producing beta cells, has hindered the development of effective disease‐modifying therapies. The discovery that the pharmacological activation of LRH‐1/NR5A2 can reverse hyperglycaemia in mouse models of T1D by attenuating the autoimmune attack coupled to beta cell survival/regeneration prompted us to investigate whether immune tolerisation could be translated to individuals with T1D by LRH‐1/NR5A2 activation and improve islet survival. Methods Peripheral blood mononuclear cells (PBMCs) were isolated from individuals with and without T1D and derived into various immune cells, including macrophages and dendritic cells. Cell subpopulations were then treated or not with BL001, a pharmacological agonist of LRH‐1/NR5A2, and processed for: (1) Cell surface marker profiling, (2) cytokine secretome profiling, (3) autologous T‐cell proliferation, (4) RNAseq and (5) proteomic analysis. BL001‐target gene expression levels were confirmed by quantitative PCR. Mitochondrial function was evaluated through the measurement of oxygen consumption rate using a Seahorse XF analyser. Co‐cultures of PBMCs and iPSCs‐derived islet organoids were performed to assess the impact of BL001 on beta cell viability. Results LRH‐1/NR5A2 activation induced a genetic and immunometabolic reprogramming of T1D immune cells, marked by reduced pro‐inflammatory markers and cytokine secretion, along with enhanced mitohormesis in pro‐inflammatory M1 macrophages and mitochondrial turnover in mature dendritic cells. These changes induced a shift from a pro‐inflammatory to an anti‐inflammatory/tolerogenic state, resulting in the inhibition of CD4+ and CD8+ T‐cell proliferation. BL001 treatment also increased CD4+/CD25+/FoxP3+ regulatory T‐cells and Th2 cells within PBMCs while decreasing CD8+ T‐cell proliferation. Additionally, BL001 alleviated PBMC‐induced apoptosis and maintained insulin expression in human iPSC‐derived islet organoids. Conclusion These findings demonstrate the potential of LRH‐1/NR5A2 activation to modulate immune responses and support beta cell viability in T1D, suggesting a new therapeutic approach. Key Points LRH‐1/NR5A2 activation in inflammatory cells of individuals with type 1 diabetes (T1D) reduces pro‐inflammatory cell surface markers and cytokine release. LRH‐1/NR5A2 promotes a mitohormesis‐induced immuno‐resistant phenotype to pro‐inflammatory macrophages. Mature dendritic cells acquire a tolerogenic phenotype via LRH‐1/NR5A2‐stimulated mitochondria turnover. LRH‐1/NR5A2 agonistic activation expands a CD4+/CD25+/FoxP3+ T‐cell subpopulation. Pharmacological activation of LRH‐1/NR5A2 improves the survival iPSC‐islets‐like organoids co‐cultured with PBMCs from individuals with T1D.

Authors 31

  1. Consejo Superior de Investigaciones Científicas · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Centro de Investigación Biomédica en Red · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Nadia Cobo‐Vuilleumier and Petra I Lorenzo Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain

  2. Universitat Autònoma de Barcelona · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

    Affiliation as printed

    Immunology Department Germans Trias i Pujol Research Institute Autonomous University of Barcelona Badalona Spain

  3. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  4. Consejo Superior de Investigaciones Científicas · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Centro de Investigación Biomédica en Red · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Nadia Cobo‐Vuilleumier and Petra I Lorenzo Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain

  5. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  6. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  7. Université Libre de Bruxelles · Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    ULB Center for Diabetes Research Medical Faculty Université Libre de Bruxelles (ULB) Brussels Belgium

  8. Consejo Superior de Investigaciones Científicas · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Centro de Investigación Biomédica en Red · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Nadia Cobo‐Vuilleumier and Petra I Lorenzo Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain

  9. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  10. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  11. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  12. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  13. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Cell and Chemical Biology Leiden University Medical Centre Leiden The Netherlands

  14. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Cell and Chemical Biology Leiden University Medical Centre Leiden The Netherlands

  15. Universitat Pompeu Fabra

    Affiliation as printed

    Pompeu Fabra University Barcelona Spain

  16. Hospital Universitario Virgen Macarena

    Affiliation as printed

    Department of Endocrinology and Nutrition University Hospital Virgen Macarena Sevilla Spain

  17. Université Libre de Bruxelles

    Affiliation as printed

    ULB Center for Diabetes Research Medical Faculty Université Libre de Bruxelles (ULB) Brussels Belgium

  18. IRCCS Ospedale San Raffaele

    Affiliation as printed

    Diabetes Research Institute IRCCS Ospedale San Raffaele Milan Italy

  19. Universidad de Cádiz · Biomedical Research and Innovation Institute of Cadiz · Hospital Universitario Puerta del Mar

    Affiliation as printed

    Department of Endocrinology and Nutrition University Hospital Puerta del Mar, Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA). University of Cádiz (UCA) Cádiz Spain

  20. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Cell and Chemical Biology Leiden University Medical Centre Leiden The Netherlands

  21. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

  22. Consejo Superior de Investigaciones Científicas · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Centro de Investigación Biomédica en Red · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Nadia Cobo‐Vuilleumier and Petra I Lorenzo Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain

  23. Universidad de Cádiz · Biomedical Research and Innovation Institute of Cadiz · Hospital Universitario Puerta del Mar

    Affiliation as printed

    Department of Endocrinology and Nutrition University Hospital Puerta del Mar, Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA). University of Cádiz (UCA) Cádiz Spain

  24. IRCCS Ospedale San Raffaele

    Affiliation as printed

    Diabetes Research Institute IRCCS Ospedale San Raffaele Milan Italy

  25. Universitat Pompeu Fabra

    Affiliation as printed

    Pompeu Fabra University Barcelona Spain

  26. Consejo Superior de Investigaciones Científicas · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Department of Cell Biology Faculty of Biology University of Sevilla Sevilla Spain

  27. Affiliation as printed

    Biobank of the Andalusian Public Health System Node Hospital Virgen Macarena Sevilla Spain

  28. Université Libre de Bruxelles

    Affiliation as printed

    ULB Center for Diabetes Research Medical Faculty Université Libre de Bruxelles (ULB) Brussels Belgium

  29. Universidad de Cádiz · Biomedical Research and Innovation Institute of Cadiz · Hospital Universitario Puerta del Mar

    Affiliation as printed

    Department of Endocrinology and Nutrition University Hospital Puerta del Mar, Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA). University of Cádiz (UCA) Cádiz Spain

  30. Universitat Autònoma de Barcelona · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

    Affiliation as printed

    Immunology Department Germans Trias i Pujol Research Institute Autonomous University of Barcelona Badalona Spain

  31. Benoit R. Gauthier corresponding

    Consejo Superior de Investigaciones Científicas · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Centro de Investigación Biomédica en Red · Centro Andaluz de Biología Molecular y Medicina Regenerativa · Universidad de Sevilla · Universidad Pablo de Olavide

    Affiliation as printed

    Andalusian Center of Molecular Biology and Regenerative Medicine‐CABIMER Junta de Andalucía‐University of Pablo de Olavide‐University of Seville‐CSIC Seville Spain

    Nadia Cobo‐Vuilleumier and Petra I Lorenzo Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain

Cited by 15 stored of 15

15 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 105